国际标准期刊号: 2573-4555

传统医学和临床自然疗法

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 参考搜索
  • 研究期刊索引目录 (DRJI)
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Discovering New Mechanisms of Traditional Chinese Medicine Compounds in Acute Kidney Injury Treatment

Kampadilemba Ouoba

Acute kidney injury (AKI) is a severe condition characterized by a sudden loss of kidney function, necessitating innovative treatment approaches. Traditional Chinese Medicine (TCM) compounds have gained attention for their potential therapeutic benefits in AKI. This article explores the discovery of new mechanisms by which TCM compounds exert their effects in AKI treatment. TCM compounds have demonstrated anti-inflammatory properties, inhibiting inflammatory pathways and reducing kidney inflammation. Additionally, they possess antioxidant properties that counteract oxidative stress-induced kidney damage. TCM compounds also modulate immune responses, regulating immune cell activation and reducing pro-inflammatory cytokine release. Promising TCM compounds, such as Astragalus membranaceus and Rheum palmatum, have shown renoprotective effects in animal models. Integrating TCM with conventional medicine could enhance patient care and treatment outcomes. However, further research and clinical trials are necessary to validate the safety, efficacy, and optimal administration of TCM compounds in AKI treatment. The exploration of TCM compounds in AKI represents a convergence of ancient wisdom and modern scientific inquiry, offering the potential for personalized and holistic care in AKI management.